Editorial policy
Every page on getpepti.app is written by Tessaro Pty Ltd, the maker of Pepti – Peptide Tracker. This page sets out how those pages are researched, what they will never contain, and how to report an error.
By Tessaro Pty Ltd, the maker of Pepti · Reviewed
Who writes these pages
We make the app this site describes, so we have a commercial interest in it, and the pages say so. The About page explains who builds Pepti. We are software developers, not clinicians. Nothing here is medical advice.
Sources we accept
A statement about what a compound is, how it acts, how long it lasts in the body or what a study found appears on this site only when it is tied to one of four kinds of source:
- PubMed — the published abstract of a peer-reviewed paper.
- PubMed Central (PMC) — the full text of a paper, where it is openly available.
- DailyMed — the current US product label for an approved medicine.
- FDA — labels and pages published by the US Food and Drug Administration.
The source is fetched and the statement is matched against the source’s own wording before it is published. Each compound reference page lists its sources with links, so you can check them yourself. Where no source of that kind exists, the page says so plainly instead of filling the gap. Several compound pages state that no reliable human half-life has been published, for exactly that reason.
Competitor facts
Our comparison pages, such as the peptide tracker comparison, describe other apps. Every fact about another app comes from that app’s own pages: its website, its App Store or Google Play listing, or its published policies. Each fact carries the month it was checked. Apps change, so verify current details on the app’s own pages before you rely on ours.
No dosing guidance
No page on this site contains a dose figure, a dose range, a schedule or a step-by-step dosing instruction, and neither does the app. The free calculators on this site (not the app) do arithmetic on figures you enter; they never choose the figure. Where an approved product exists, its dosing belongs to its label and to whoever directs your care.
What we do not publish
We do not publish ratings, reviews, download counts or testimonials that we cannot verify, and we do not promise results. Pepti is a record-keeping tool, and the site describes it as one.
Review dates
Content pages show the month they were last reviewed, near the top and in the footer. The date changes only when the page has been re-checked against its sources.
How pages are produced
Drafting is assisted by software, including AI writing tools. Every factual statement is checked against its source before publication, and Tessaro Pty Ltd is responsible for everything published here.
The citation standard, line by line
- Author, journal, year — every trial or mechanism claim names the first author, the journal and the year in the sentence that makes it.
- A working PubMed link — each cited paper is linked, either by its PubMed record or by a PubMed search that returns it first. Labels link to the DailyMed record.
- Sources (N) means N — the number in a page’s Sources heading equals the number of linked items beneath it.
- Numbers are checked against the abstract — a percentage, ratio or duration appears only if it is in the cited paper’s abstract or its openly available full text.
- Half-lives from human studies or labels only — a half-life is stated only where a human pharmacokinetic study or an approved label reports one; otherwise the page says none has been published.
- Quotations are verbatim — text in quotation marks is matched against the fetched source word for word.
The site is re-audited against this list periodically. The most recent full audit, in October 2026, checked every PubMed link on the site, 67 of them, and every cited statistic; all matched their sources.
Corrections we have made
Corrections are part of the record, so here are the substantive ones to date. In September 2026 the retatrutide half-life was corrected to the published figure of about six days. In September 2026 every statement that data stays on the device was qualified for the optional AI coach and lab-report import, which do send data to our server. In October 2026, statements implying a free trial were removed, because Pepti has none; a Sources heading whose count did not match its items was fixed; and two pages that quoted a 2023 retatrutide trial without listing it gained the missing citation.
What a reader can check in two minutes
Open any compound page, find the Sources heading, and count: the number should match the links. Click one; it should land on PubMed or DailyMed, at a paper or label whose first author, journal and year match the sentence. Look for the review date near the top; it is the month the page was last checked against those sources. If any of those three checks fails, the address below is the place to say so.
Report an error
If you find a mistake, email support@tessaro.com.au with the page address and the sentence in question. We correct confirmed errors and update the page’s review date. For how the app itself handles your data, see the peptide tracking app guide.
Get Pepti on the App StorePepti – Peptide Tracker · Reviewed October 2026 · Editorial policy · About
Not medical advice. Pepti is a record-keeping tool, not a medical device.